Financing ·
VolitionRx issues 1,413,450 shares to settle $465,000 in convertible note obligations
VNRXVolitionrx Ltd
VolitionRx Limited issued shares of common stock to Lind Global Asset Management XII LLC to satisfy conversion obligations under senior secured convertible promissory notes. On September 2, 2026, the company issued 706,214 shares to settle a $250,000 obligation, and on September 10, 2026, it issued 707,236 shares to satisfy a $215,000 obligation. As of September 14, 2026, there were 27,903,326 shares of common stock issued and outstanding. VolitionRx Limited operates in the healthcare diagnostics industry, developing molecular diagnostic tests for cancer detection.